ALTER
vs
ABT
ALTER
ABT
Over the past 12 months, ALTER has underperformed ABT, delivering a return of 0% compared to the ABT's 17% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ALTER
ABT
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Theradiag SA
PAR:ALTER
|
1.26
EUR
|
|||||
|
Abbott Laboratories
NYSE:ABT
|
109.155
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
ALTER, ABT
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Theradiag SA
Revenue
|
|||||||||||
|
Abbott Laboratories
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
ALTER, ABT
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Theradiag SA
PAR:ALTER
|
|||||||||
|
Abbott Laboratories
NYSE:ABT
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
ALTER, ABT
Performance Gap
ALTER, ABT
Performance By Year
ALTER, ABT
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.